Am J Perinatol 2008; 25(3): 169-174
DOI: 10.1055/s-2008-1061503
© Thieme Medical Publishers

Glyburide Metabolism by Placentas of Healthy and Gestational Diabetics

Sangeeta Jain1 , Olga L. Zharikova1 , Selvan Ravindran1 , Tatiana N. Nanovskya1 , Donald R. Mattison2 , Gary D.V Hankins1 , Mahmoud S. Ahmed1
  • 1Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston, Texas
  • 2Obstetric & Pediatric Pharmacology Branch, National Institute of Child Health and Human Development, Rockville, Maryland
Further Information

Publication History

Publication Date:
25 February 2008 (online)

ABSTRACT

The aim of this investigation was to determine the metabolism of glyburide (GL) by microsomes prepared from placentas obtained from uncomplicated pregnancies (UP), women with gestational diabetics (GD) on a diabetic diet, and those on a diet and GL. Term placentas were obtained from UP and GD. Crude microsomal fractions were prepared by differential centrifugation and stored at -80°C. The activity of the microsomes in metabolizing glyburide to the trans-4-hydroxycyclohexyl glyburide (THCGL) and cis-3-hydroxycyclohexyl glyburide (CHCGL) was determined and quantified using high-performance liquid chromatography-mass spectrometer (HPLC-MS). The activity of the placental microsomes varied widely between individual placentas in each group. The median values (pmol·mg-1 P·min-1) for the rates of THCGL formation were 0.34, 0.3, and 0.23 for placentas of UP, GD on diet, and GD on GL and a diet, respectively. The median values for CHCGL formation were 0.13 for UP, 0.11 for GD on a diet, and 0.10 (pmol·mg-1 P·min-1) for GD on GL and a diet. A pool of individual microsomal fractions from each group was prepared and its activity revealed the following: greater formation of THCGL in the UP (0.36 ± 0.10) than GD (0.22 ± 0.03) (p = 0.058 for GD on a diet, 0.04 for GD on GL). There was greater formation of CHCGL in UP (0.26 ± 0.04) than GD (0.12 ± 0.003) (p < 0.006). There was no difference in GD on a diet and GD on GL plus diet. We concluded that the apparent differences in the formation of metabolites may be statistically significant, but it is unlikely to be of physiological importance, given the sample size and other experimental factors. Therefore, a more comprehensive investigation is underway.

REFERENCES

  • 1 Coustan D R. Gestational diabetes. In: National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes in America. 2nd ed. Bethesda, MD; NIDDK 1995 NIH Publication No. 95-1468 703-717
  • 2 Berkus M D, Conway D, Langer O. The large fetus.  Clin Obstet Gynecol. 1999;  42 766-784
  • 3 Rochon M, Rand L, Roth L, Gaddipati S. Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes.  Am J Obstet Gynecol. 2006;  195 1090-1094
  • 4 Belser F, Brogli H, Constam G, Zollikofer H. Testing a new antidiabetic (Glibenclamide) in hospitalized and ambulatory diabetics.  Schweiz Rundsch Med Prax. 1970;  59 598-601
  • 5 Davis S N. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Brunton L, Parker K, Buxton I, Blumenthal D Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York; McGraw-Hill 2006: 1634
  • 6 Christ O E, Heptner W, Rupp W. Investigations of absorption, excretion and metabolism in man after administration of 14C-labelled HB 419.  Horm Metab Res. 1969;  1(supp 1) 149-153
  • 7 Kirchheiner J, Brockmoller J, Meineke I et al.. Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers.  Clin Pharmacol Ther. 2002;  71 286-296
  • 8 Elliott B D, Langer O, Schenker S, Johnson R F. Insignificant transfer of glyburide occurs across the human placenta.  Am J Obstet Gynecol. 1991;  165 807-812
  • 9 Nanovskaya T N, Nekhayeva I, Hankins G D, Ahmed M S. Effect of human serum albumin on transplacental transfer of glyburide.  Biochem Pharmacol. 2006;  72 632-639
  • 10 Kraemer J, Klein J, Lubetsky A, Koren G. Perfusion studies of glyburide transfer across the human placenta: implications for fetal safety.  Am J Obstet Gynecol. 2006;  195 270-274
  • 11 Rydberg T, Wahlin-Boll E, Melander A. Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography.  J Chromatogr. 1991;  564 223-233
  • 12 Ravindran S, Zharikova O L, Hill R A, Nanovskaya T N, Hankins G D, Ahmed M S. Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons.  Biochem Pharmacol. 2006;  72 1730-1737
  • 13 Rupp W, Christ O, Heptner W. Resorption, Ausscheidung und Metabolismus nach intravenoser und oraler gabe von HB 419-14C and menschen.  Arzneimittelforschung. 1969;  19 1428-1434
  • 14 Kim K A, Park J Y. Inhibitory effect of glyburide on human cytochrome P450 isoforms in human liver microsomes.  Drug Metab Dispos. 2003;  31 1090-1092
  • 15 Hill R A, Rudra S, Peng B et al.. Hydroxyl-substituted sulfonylureas as potent inhibitors of specific [3H] glyburide binding to rat brain synaptosomes.  Bioorg Med Chem. 2003;  11 2099-2113
  • 16 American Diabetic Association . Gestational diabetes mellitus (position statement).  Diabetes Care. 2002;  25(suppl 10) s94-96
  • 17 Deshmukh S V, Nanovskaya T N, Ahmed M S. Aromatase is the major enzyme metabolizing buprenorphine in human placenta.  J Pharmacol Exp Ther. 2003;  306 1099-1105
  • 18 Nanovskaya T N, Deshmukh S V, Nekhayeva I A, Zharikova O L, Hankins G D, Ahmed M S. Methadone metabolism by human placenta.  Biochem Pharmacol. 2004;  68 583-591
  • 19 Zharikova O L, Ravindran S, Nanovskaya T N, Hill R A, Hankins G D, Ahmed M S. Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon.  Biochem Pharmacol. 2007;  73 2012-2019
  • 20 Kasai K, Shik S S, Yoshida Y. Production and localization of human prolactin in placenta and decidua in early and term normal pregnancy.  Int Biol Res Pregnancy. 1982;  3 25-29
  • 21 Taylor C M, Stevens H, Anthony F W, Wheeler T. Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotropin production in the trophoblast-derived cell lines: JEG, JAr, and BeWo.  Placenta. 1997;  18 451-458
  • 22 Yang W, Ahn H, Hinrichs M et al.. Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells.  J Reprod Immunol. 2003;  60 53-60
  • 23 Nanovskaya T, Nekhayeva I, Karunaratne N, Audus K, Hankins G D, Ahmed M S. Role of P-glycoprotein in transplacental transfer of methadone.  Biochem Pharmacol. 2005;  69 1869-1878

Mahmoud S AhmedPh.D. 

Department of Obstetrics & Gynecology, University of Texas Medical Branch

301 University Boulevard, Galveston, TX 77555-0587

    >